Navigation Links
Video: Data From 185,000 ICU Admissions Show Significant Reductions in Mortality:
Date:5/20/2008

actices/icu_physician_staffing) documented numerous studies that show intensivist staffing reduces the risk of ICU mortality by up to 40 percent, but less than a third of patients nationwide have access to these specialists.

"24/7 intensivist-led care has become a necessity, not a luxury, and this program is the only identified way to address the growing critical care crisis resulting from aging baby boomers and the shortage of critical care doctors and nurses," said Dr. Brian Rosenfeld, VISICU chief medical officer (http://www.visicu.com/company/clinicalbios.html). "The numbers are compelling -- when all hospitals nationwide begin to effectively integrate remote intensivist support with technology in their critical care models, more than 100,000 additional lives will be saved each year. Patient conditions in the ICU can change in a matter of minutes, and we owe it to patients -- and their families -- to deliver the highest quality care around-the-clock 7 days a week."

Approximately 200 hospitals and 40 health systems nationwide currently serve more than 300,000 ICU patients each year through eICU Centers located across 28 states. The eICU Centers are operated by organizations ranging from academic medical centers to integrated community health systems. Using advanced eICU software and hardware, one intensivist physician and two critical care nurses can support up to 120 ICU beds at a time.

Sutter Health

Sutter Health (http://www.sutterhealth.org/about/patientsafety/ps_eicu.html), a 27-hospital system based in Sacramento, Calif., opened its first eICU Center in 2003 and a second in 2005. The two centers monitor more than 400 ICU beds at 24 hospitals across a wide geographic area in Northern California.

"Sutter Health's eICU Centers have assisted our ICU partners in redu
'/>"/>

SOURCE VISICU, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Video: New Survey Finds Technology Plays a Critical Role in Lives of People with Multiple Sclerosis, Yet Many Are Not Using it to Overcome Disease-Related Challenges
2. Video: Trinity Mother Frances Neurosurgeon Using New Disc System for Patients With Degenerative Diseases of the Neck
3. Treatment with Paliperidone ER May Be Associated with Significantly Reduced Use of Mental Health Resources
4. Cord Blood America CEO Matthew Schissler Says Operations Significantly Streamlined
5. Oral PBI-1402 Demonstrates Significant Activity in Chemotherapy-Induced Anemia Phase II Clinical Trial
6. Significant Reductions in Mortality and Cardiovascular Events Shown Using Blood Pressure-Lowering Treatment in Those Aged 80 and Over
7. Micromet to Present at the Susquehanna Financial Groups SIGnificant Investment Options Conference on March 4, 2008
8. Kosan Biosciences to Present at the Susquehanna Second Annual SIGnificant Options in Healthcare Conference
9. Exelixis Announces March 4 Webcast of Presentation at the Susquehanna SIGnificant Options in Healthcare Conference
10. InterMune to Present at the SIGnificant Options in Healthcare Conference
11. ViroPharma to Present at the Susquehanna Financial Group Second Annual Significant Options in Healthcare Conference

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)...wswire-Asia/ -- The pharma and biotech sectors are...nies are facing significant,pressure to change wit...calls for,lower prices and a greater regulatory bu... crisis have made the work of creating new drugs h...being forced to globalize their R&D,operations...
(Date:11/9/2009)...t release is a research industry first, allowing v...nd research safety study data to be managed in one...Cedar Knolls, NJ (PRWEB) November 9, 2009 -- Xybio...iled Pristima™ VM, an integrated enterprise ...ck the use and care of veterinary research subject...
(Date:11/7/2009)... Research projects in the areas of ... evening, as Tim Kunisky of Livingston, NJ and the...ubon, PA received the highest honors at the Region...th, Science & Technology, the nation,s premier...www.newscom.com/cgi-bin/prnh/20070904/SIEMENSLOGO ...
(Date:11/6/2009)...ewswire/ -- Myriant Technologies LLC ("Myriant"), ...er of renewable bio-chemicals, Uhde Corporation o...de GmbH, one of the world,s leading engineering co...for the engineering, procurement & constructio... based on renewable feedstocks. The execution of ...
Breaking Biology Technology:Pharma and Biotech Leaders to Converge in Shanghai 2Xybion Unveils Pristima™ VM, an Integrated Enterprise Software Solution for Vivarium and Veterinary Care Management 2Mathematics and Biochemistry Research Earn Top Prize at Nation's Premier High School Science Competition 2Mathematics and Biochemistry Research Earn Top Prize at Nation's Premier High School Science Competition 3Mathematics and Biochemistry Research Earn Top Prize at Nation's Premier High School Science Competition 4Mathematics and Biochemistry Research Earn Top Prize at Nation's Premier High School Science Competition 5Mathematics and Biochemistry Research Earn Top Prize at Nation's Premier High School Science Competition 6Myriant Technologies LLC, Uhde Corporation of America and Uhde GmbH Announce Alliance for Engineering, Procurement & Construction of World Scale Renewable Succinic Acid Plants 2Myriant Technologies LLC, Uhde Corporation of America and Uhde GmbH Announce Alliance for Engineering, Procurement & Construction of World Scale Renewable Succinic Acid Plants 3
...ed for the First Time on 50 mg/Day Dose for PRISTI...ssive Disorder, COLLEGEVILLE, Pa., Dec. 12 Wyeth...), announces that data from,two Phase 3 clinical s...gational serotonin-norepinephrine reuptake inhibit... a 50 mg/day dose of PRISTIQ for the,treatment of ...
...he Netherlands, December 12 , - Forty-five Presti...Response to Customer Demand, Elsevier, a leading ...M) information, today announced that 45 French-lan...e available on ScienceDirect beginning January,3, ...gie, Journal de Chirurgie and,La Press Medicale, r...
...IND has Been Filed With the FDA for the Fourth Gen...Collaboration with Roche., COPENHAGEN, December 1...nvestigational New Drug application (IND) for a,Ge...oration with Roche has,been filed with the FDA by ...velopment of the antibody which selectively blocks...
Other Biology Technology:New Phase 3 Data Showed PRISTIQ Significantly Reduced Symptoms of Major Depressive Disorder Versus Placebo 2New Phase 3 Data Showed PRISTIQ Significantly Reduced Symptoms of Major Depressive Disorder Versus Placebo 3New Phase 3 Data Showed PRISTIQ Significantly Reduced Symptoms of Major Depressive Disorder Versus Placebo 4New Phase 3 Data Showed PRISTIQ Significantly Reduced Symptoms of Major Depressive Disorder Versus Placebo 5New Phase 3 Data Showed PRISTIQ Significantly Reduced Symptoms of Major Depressive Disorder Versus Placebo 6ScienceDirect to Host French-Language Journals from Elsevier Masson 2ScienceDirect to Host French-Language Journals from Elsevier Masson 3Fourth Genmab Antibody Developed Under Roche Collaboration to Enter Clinic 2Fourth Genmab Antibody Developed Under Roche Collaboration to Enter Clinic 3
(Date:11/4/2009)...t Norman has received more than $10 million in res... the federal stimulus program, bringing thetotal a...rs to $23 million. Thirty-three projects achieved...logy to weather. , "The university has thoughtfu...reasof scholarly excellence to federal agency prio...
(Date:11/4/2009)...PRNewswire-FirstCall/ -- Quest Diagnostics Incorpo...of diagnostic testing, information and services, a...r 30, 2009, income from continuing operations rose... $160 million, or $0.81 per diluted share, for the...ults were reduced by a $0.03 per share charge asso...
(Date:11/4/2009)... Aware, Inc. (Nasdaq: AW...nd biometrics software, today reported financial r...2009. ,, Michael Tzannes, Aware,s Chairman an...e announced an agreement to sell our DSL and home ...semiconductor company being spun out of Infineon. ...
Breaking Biology News(10 mins):OU achieves $10 million in stimulus grants for 33 projects on the Norman campus 2OU achieves $10 million in stimulus grants for 33 projects on the Norman campus 3Quest Diagnostics Reports Strong Performance in Third Quarter 2009 2Quest Diagnostics Reports Strong Performance in Third Quarter 2009 3Quest Diagnostics Reports Strong Performance in Third Quarter 2009 4Quest Diagnostics Reports Strong Performance in Third Quarter 2009 5Quest Diagnostics Reports Strong Performance in Third Quarter 2009 6Quest Diagnostics Reports Strong Performance in Third Quarter 2009 7Quest Diagnostics Reports Strong Performance in Third Quarter 2009 8Quest Diagnostics Reports Strong Performance in Third Quarter 2009 9Quest Diagnostics Reports Strong Performance in Third Quarter 2009 10Quest Diagnostics Reports Strong Performance in Third Quarter 2009 11Quest Diagnostics Reports Strong Performance in Third Quarter 2009 12Quest Diagnostics Reports Strong Performance in Third Quarter 2009 13Quest Diagnostics Reports Strong Performance in Third Quarter 2009 14Quest Diagnostics Reports Strong Performance in Third Quarter 2009 15Quest Diagnostics Reports Strong Performance in Third Quarter 2009 16Quest Diagnostics Reports Strong Performance in Third Quarter 2009 17Aware, Inc. Reports Third Quarter 2009 Financial Results 2Aware, Inc. Reports Third Quarter 2009 Financial Results 3Aware, Inc. Reports Third Quarter 2009 Financial Results 4Aware, Inc. Reports Third Quarter 2009 Financial Results 5Aware, Inc. Reports Third Quarter 2009 Financial Results 6Aware, Inc. Reports Third Quarter 2009 Financial Results 7Kensey Nash Announces Agreement to Acquire Rights to OsseoFit Product 13449 1Kensey Nash Announces Agreement to Acquire Rights to OsseoFit Product 13449 2Kensey Nash Announces Agreement to Acquire Rights to OsseoFit Product 13449 3EGEN Inc Announces the Promotion of Jason Fewell Ph D to Vice President of Preclinical Research and Development 13448 1EGEN Inc Announces the Promotion of Jason Fewell Ph D to Vice President of Preclinical Research and Development 13448 2NeurogesX Reports Second Quarter 2009 Results 13446 1NeurogesX Reports Second Quarter 2009 Results 13446 2NeurogesX Reports Second Quarter 2009 Results 13446 3NeurogesX Reports Second Quarter 2009 Results 13446 4NeurogesX Reports Second Quarter 2009 Results 13446 5NeurogesX Reports Second Quarter 2009 Results 13446 6NeurogesX Reports Second Quarter 2009 Results 13446 7NeurogesX Reports Second Quarter 2009 Results 13446 8NeurogesX Reports Second Quarter 2009 Results 13446 9NeurogesX Reports Second Quarter 2009 Results 13446 10NeurogesX Reports Second Quarter 2009 Results 13446 11NeurogesX Reports Second Quarter 2009 Results 13446 12
...rrow Neurological Institute at St. Joseph,s Hospit...k between eye motions and the perception of illuso...Stephen Macknik, PhD, director of the Laboratory o...e, PhD, director of the Laboratory of Visual Neuro...illan; conducted a study based on the Enigma paint...
... have grown soybeans and turned them into many use...hy a soybean grows, blooms or produces like it doe... , University of Georgia professor Wayne Parrott...million grant from the National Science Foundation...ue. , "I,m convinced that soybeans would be so mu...
... city dwellers posed by Southern California wildfi...restimated by officials. , Detailed particulate a...ia wild fires indicates that the composition posed...generally realized, according to a new paper analy...thern California. , The paper, entitled "Physico...
Other Biology News:Soybean grant gives researchers tools to unravel better bean 2Where there's wildfire smoke, there's toxicity 2
Mouse Anti-Human CAPG Monoclonal Antibody, Unconjugated, Clone 6D6 from Abnova Corporation
GeneSnap from SYNGENE
DISCOVERLIGHT 6XHIS ARRAY from Pierce Biotechnology, Inc.
Mouse Anti-XAGE2 Polyclonal Antibody, Unconjugated from Abnova Corporation
Biology Products: